Costs and Clinical Outcomes Associated with Use of Ranolazine for Treatment of Angina.

Trial Profile

Costs and Clinical Outcomes Associated with Use of Ranolazine for Treatment of Angina.

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Jul 2012

At a glance

  • Drugs Ranolazine (Primary) ; Beta-adrenergic receptor antagonists; Calcium channel antagonists; Organic nitrates
  • Indications Angina pectoris
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Jul 2012 New trial record
    • 16 May 2012 Results published in Clinical Therapeutics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top